<DOC>
	<DOCNO>NCT00728299</DOCNO>
	<brief_summary>Increases carotid artery intima-media thickness ( IMT ) correlate increase risk stroke myocardial infarction . The purpose study ass pomegranate juice retard carotid ( IMT ) progression rate men woman one exist cardiovascular risk factor ( current cigarette smoking , hypertension , low HDL-cholesterol , and/or high LDL-cholesterol ) upon entrance study .</brief_summary>
	<brief_title>The Effects Consumption Pomegranate Juice Carotid Intima-Media Thickness</brief_title>
	<detailed_description>Previous study atherosclerotic mouse show pomegranate supplementation reduce macrophage oxidative stress attenuate development atherosclerosis . Further research hypertensive human demonstrate pomegranate juice angiotensin convert enzyme ( ACE ) -inhibitory effect significantly decrease systolic blood pressure . This study use randomize , double-blind , placebo-controlled design eight clinic visit ( one screen visit [ week -4 -1 ] , one baseline visit [ week 0 ] , six treatment visit [ week 13 , 26 , 38 , 52 , 65 , 78 ] ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Males age 45 74 female age 55 74 year . Subject ≥ 1 follow risk factor Visit 1 ( week 4 1 ) : current cigarette smoking ( define cigarette smoking within past month ) hypertension ( blood pressure ≥ 140/90 mm Hg use antihypertensive medication ) low HDL cholesterol ( &lt; 40 mg/dL ) high LDL cholesterol ( ≥ 130 mg/dL &lt; 190 mg/dL ) , statin therapy Posterior wall common carotid IMT &gt; 0.7 mm &lt; 2.0 mm Visit 2 ( week 0 ) adequate image least one side . Subject understands study procedure sign inform consent form . Normally active judge good health basis medical history , physical examination , routine laboratory test . Use pharmacologic lipidaltering medication , besides statin ( e.g. , fibrate derivative , bile acid binding resin , niacin analogue dose &gt; 400 mg/d ) six week prior Visit 1 Body mass index &gt; 40 kg/m2 . Unstable use ( &lt; 2 month prior Visit 1 ) supplement know alter lipid metabolism , include limited : dietary fiber supplement ( include &gt; 2 teaspoon Metamucil® psylliumcontaining supplement per day ) , omega3 fatty acid supplement , sterol/stanol product , red rice yeast supplement , garlic supplement , soy isoflavone supplement others discretion Investigator ) . History pomegranate consumption ( either eat pomegranate drink pomegranate juice ) within past 6 month . Clinical evidence history coronary heart disease ( CHD ) CHD equivalents include : diabetes mellitus , angina , myocardial infarction , transient ischemic attack , symptomatic carotid artery disease , cerebrovascular accident , coronary artery bypass grafting , percutaneous transluminal coronary angioplasty , peripheral arterial disease , abdominal aortic aneurysm , ankle brachial index &lt; 0.90 , and/or Framingham Risk Score ≥ 16 point men ≥ 23 point woman ( 10year CHD risk &gt; 20 % ) Active cancer , nonmelanoma skin cancer , within previous two year . Prior diagnosis human immunodeficiency virus ( HIV ) hepatitis B hepatitis C. Uncontrolled hypertension ( average systolic blood pressure ≥ 160 mm Hg and/or average diastolic blood pressure ≥ 100 mm Hg ) . Untreated unstable hypothyroidism ( receive stable dose therapy &lt; 4.0 month ) . Concomitant use betaadrenergic blocker immunosuppressant Concomitant use estrogen progestin therapy . Allergy pomegranates pomegranate juice . Known allergy blood product . NonEnglish speaking . Active liver disease hepatic dysfunction define elevation ≥ 2.0 x ULN Visit 1 follow liver function test : ALT , AST bilirubin . Serum creatinine &gt; 2.0 mg/dL record screening period . Recent history ( within past 12 month ) strong potential alcohol substance abuse . Alcohol abuse define &gt; 14 drink per week ( 1 drink = 12 oz beer , 4 oz wine , 1 ½ oz distil spirit ) . Participation another clinical study within 30 day prior screen visit 1 ( week 4 1 ) . Has condition Investigator believe would interfere evaluation subject , may put subject undue risk . Posterior wall common carotid IMT ≥ 2.0 mm either side Visit 2 ( week 0 ) .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Coronary artery disease , carotid intima-media thickness</keyword>
</DOC>